Rabbit Recombinant Monoclonal PTPRH antibody. Suitable for ICC/IF, WB and reacts with Human samples. Cited in 1 publication.
Preservative: 0.01% Sodium azide
Constituents: 59.94% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
ICC/IF | IP | Flow Cyt | WB | IHC-P | |
---|---|---|---|---|---|
Human | Tested | Not recommended | Not recommended | Tested | Not recommended |
Mouse | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Rat | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/50 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Protein phosphatase that may contribute to contact inhibition of cell growth and motility by mediating the dephosphorylation of focal adhesion-associated substrates and thus negatively regulating integrin-promoted signaling processes. Induces apoptotic cell death by at least two distinct mechanisms: inhibition of cell survival signaling mediated by PI 3-kinase, Akt, and ILK and activation of a caspase-dependent proapoptotic pathway. Inhibits the basal activity of LCK and its activation in response to TCR stimulation and TCR-induced activation of MAP kinase and surface expression of CD69. Inhibits TCR-induced tyrosine phosphorylation of LAT and ZAP70. Inhibits both basal activity of DOK1 and its CD2-induced tyrosine phosphorylation. Induces dephosphorylation of BCAR1, focal adhesion kinase and SRC. Reduces migratory activity of activity of Jurkat cells. Reduces tyrosine phosphorylation of CEACAM20 and thereby contributes to suppress the intestinal immune response CEACAM20 (By similarity).
SAP1, PTPRH, Receptor-type tyrosine-protein phosphatase H, R-PTP-H, Stomach cancer-associated protein tyrosine phosphatase 1, Transmembrane-type protein-tyrosine phosphatase type H, SAP-1
Rabbit Recombinant Monoclonal PTPRH antibody. Suitable for ICC/IF, WB and reacts with Human samples. Cited in 1 publication.
Preservative: 0.01% Sodium azide
Constituents: 59.94% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
PTPRH also known as human protein tyrosine phosphatase receptor type H (SAP-1) is a receptor-type protein tyrosine phosphatase. It weighs around 130 kDa. This protein is mainly found in epithelial tissues including the liver pancreas stomach and intestines. PTPRH contains an extracellular domain a single transmembrane region and an intracellular catalytic domain playing a significant role in dephosphorylation processes.
PTPRH functions as a regulator of cellular signaling processes by modulating phosphorylation levels. It acts in the cellular communication network impacting cell growth differentiation and adhesion. This protein does not usually exist as part of a larger complex but interacts directly with phosphorylated substrates to exert its activity. PTPRH’s role in modulating signal transduction affects various cellular processes from metabolism to immune responses.
PTPRH shows involvement in the MAPK/ERK signaling pathway and the PI3K/AKT signaling pathway. These pathways are important for transmitting extracellular signals to regulate gene expression and cell survival. PTPRH impacts molecular partners such as ERK and AKT through dephosphorylation influencing cellular responses. Its activity also integrates with other signaling molecules ensuring accurate control over cellular functions.
PTPRH associates with several pathologies with notable implications in cancer and liver disease. Loss of PTPRH function or alterations in its expression levels have been linked to colorectal cancer development due to disrupted cellular signaling. Additionally changes in PTPRH activity can affect proteins like EGFR which plays a part in cell proliferation and survival further connecting it to oncogenic processes. Understanding PTPRH's role provides insights into mechanisms leading to disease progression and potential therapeutic targets.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Negative control: SW480 and Low expression: HCT 116 (PMID: 28713969).
Exposure time: 37 seconds.
All lanes: Western blot - Anti-PTPRH antibody [EPR20897-15] (ab231767) at 1/1000 dilution
Lane 1: HT-29 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2: HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3: SW480 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4: A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 122 kDa
Observed band size: 250 kDa
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HT-29 cells labelling PTPRH with ab231767 at 1/50 (11.42 ug/ml) dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) antibody at 1/1000 dilution (Green). Confocal image showing cytoplasmic staining in HT-29 cell line. Negative control: SW480 PMID: 28713969). Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control: Secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1/1000 dilution.
Blocking and diluting buffer and concentration: 5% NFDM/TBST
Exposure time: 59 seconds.
All lanes: Western blot - Anti-PTPRH antibody [EPR20897-15] (ab231767) at 1/1000 dilution
Lane 1: HT-29 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2: HT-29 whole cell lysate treated with PNGase F at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 122 kDa
Observed band size: 122 kDa, 250 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com